FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005511495> ?p ?o ?g. }

• W3005511495 endingPage "1002" @default.
• W3005511495 startingPage "996" @default.
• W3005511495 abstract "To described the clinical and laboratory features and outcome of 67 macrophage activation syndrome (MAS).A total of 67 MAS patients from three centers from January 2007 to December 2017 were enrolled. Clinical and laboratory features, and response to therapy were analyzed. Predictive factors for remission and survival were explored.We identified a mean age of (36.1±16.3) years at diagnosis of MAS and a median connective tissue disease (CTD) duration of 8 months prior to MAS development. Among 67 MAS patients identified, underlying diseases included adult-onset Still's disease (AOSD) in 56.7% and systemic lupus erythematosus (SLE) in 30.0%. Fever and splenomegaly were found in 100.0% and 82.1% of the patients, respectively. Ferritinemia and elevation of serum soluble interleukin-2 receptor was seen in 100.0% and 93.2% of the patients. Serum levels of alanine aminotransferase, D-dimer, ferritin and C reactive protein were significantly higher in MAS associated with the AOSD patients than in MAS associated with the SLE patients. A significant decrease of erythrocyte sedimentation rate was found in MAS associated with AOSD, as compared with MAS associated with SLE. The most commonly used therapy was corticosteroids, which were initially administered in 100.0% of the patients. Intravenous immunoglobulin (IVIG) was administered in 91.0%, cyclosporine A in 64.2%, and etoposide in 46.3% of the patients, respectively. The induction therapy yielded a complete remission (CR) at the end of week 8 in 47.8% of the MAS patients. The overall mortality rate at the end of week 16 was 22.4%. The median serum levels of gamma-glutamyltransferase, alkaline phosphatase, total bilirubin and direct bilirubin were significantly lower in the patients who achieved complete remission at the end of week 8 than in those who did not, and splenomegaly was significantly less frequent (71.9% vs.91.4%, P=0.037). Both the mean age at diagnosis of MAS and the mean age at diagnosis of underlying CTD of the deceased patients were elder than those of the survived population (P=0.014 and P=0.017, respectively). The platelet count was significantly less in the deceased population as compared with the living population (P=0.018). No addition of cyclosporine A (P=0.004) was identified as risk factors associated with death in Logistic regression analysis.MAS secondary to connective tissue disease is most common with AOSD and SLE. In terms of laboratory findings, there were considerable differences between the patients with underlying SLE and those with AOSD. Advanced age and low platelet counts are significant predictive factors for death, while treatment with cyclosporine may reduce the risk." @default.
• W3005511495 created "2020-02-14" @default.
• W3005511495 creator A5006571309 @default.
• W3005511495 creator A5008376747 @default.
• W3005511495 creator A5019829279 @default.
• W3005511495 creator A5032653868 @default.
• W3005511495 creator A5038771597 @default.
• W3005511495 creator A5054173061 @default.
• W3005511495 creator A5071881012 @default.
• W3005511495 date "2019-12-18" @default.
• W3005511495 modified "2023-09-26" @default.
• W3005511495 title "[Clinical characteristics and treatment outcomes of macrophage activation syndrome in adults: A case series of 67 patients]." @default.
• W3005511495 cites W1585868534 @default.
• W3005511495 cites W1909467642 @default.
• W3005511495 cites W1978089430 @default.
• W3005511495 cites W1983206910 @default.
• W3005511495 cites W1998454545 @default.
• W3005511495 cites W2061040114 @default.
• W3005511495 cites W2064037171 @default.
• W3005511495 cites W2068646465 @default.
• W3005511495 cites W2105786846 @default.
• W3005511495 cites W2162251899 @default.
• W3005511495 cites W2163067702 @default.
• W3005511495 cites W2164925047 @default.
• W3005511495 cites W2188969807 @default.
• W3005511495 cites W2265918137 @default.
• W3005511495 cites W2337852073 @default.
• W3005511495 cites W2410423454 @default.
• W3005511495 cites W2418742431 @default.
• W3005511495 cites W2607273843 @default.
• W3005511495 cites W2755192480 @default.
• W3005511495 cites W2883411566 @default.
• W3005511495 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7433608" @default.
• W3005511495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31848493" @default.
• W3005511495 hasPublicationYear "2019" @default.
• W3005511495 type Work @default.
• W3005511495 sameAs 3005511495 @default.
• W3005511495 citedByCount "0" @default.
• W3005511495 crossrefType "journal-article" @default.
• W3005511495 hasAuthorship W3005511495A5006571309 @default.
• W3005511495 hasAuthorship W3005511495A5008376747 @default.
• W3005511495 hasAuthorship W3005511495A5019829279 @default.
• W3005511495 hasAuthorship W3005511495A5032653868 @default.
• W3005511495 hasAuthorship W3005511495A5038771597 @default.
• W3005511495 hasAuthorship W3005511495A5054173061 @default.
• W3005511495 hasAuthorship W3005511495A5071881012 @default.
• W3005511495 hasConcept C126322002 @default.
• W3005511495 hasConcept C203014093 @default.
• W3005511495 hasConcept C2776914184 @default.
• W3005511495 hasConcept C2778143017 @default.
• W3005511495 hasConcept C2779134260 @default.
• W3005511495 hasConcept C2779613421 @default.
• W3005511495 hasConcept C57194454 @default.
• W3005511495 hasConcept C71924100 @default.
• W3005511495 hasConcept C90924648 @default.
• W3005511495 hasConceptScore W3005511495C126322002 @default.
• W3005511495 hasConceptScore W3005511495C203014093 @default.
• W3005511495 hasConceptScore W3005511495C2776914184 @default.
• W3005511495 hasConceptScore W3005511495C2778143017 @default.
• W3005511495 hasConceptScore W3005511495C2779134260 @default.
• W3005511495 hasConceptScore W3005511495C2779613421 @default.
• W3005511495 hasConceptScore W3005511495C57194454 @default.
• W3005511495 hasConceptScore W3005511495C71924100 @default.
• W3005511495 hasConceptScore W3005511495C90924648 @default.
• W3005511495 hasIssue "6" @default.
• W3005511495 hasLocation W30055114951 @default.
• W3005511495 hasOpenAccess W3005511495 @default.
• W3005511495 hasPrimaryLocation W30055114951 @default.
• W3005511495 hasRelatedWork W2056067227 @default.
• W3005511495 hasRelatedWork W2114130281 @default.
• W3005511495 hasRelatedWork W2163793238 @default.
• W3005511495 hasRelatedWork W2320240246 @default.
• W3005511495 hasRelatedWork W2376405497 @default.
• W3005511495 hasRelatedWork W2794344514 @default.
• W3005511495 hasRelatedWork W2961481644 @default.
• W3005511495 hasRelatedWork W3032762808 @default.
• W3005511495 hasRelatedWork W3139529204 @default.
• W3005511495 hasRelatedWork W4229441630 @default.
• W3005511495 hasVolume "51" @default.
• W3005511495 isParatext "false" @default.
• W3005511495 isRetracted "false" @default.
• W3005511495 magId "3005511495" @default.
• W3005511495 workType "article" @default.